MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jneuroim.2021.577506

Медицинская библиотека · Journal of neuroimmunology · 2021

The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China.

Li Cong, Wang Jingqi, Sun Xiaobo, Li Rui, Chang Yanyu, Wang Yuge, Zhong Xiaonan, Kermode Allan G, Mao Zhifeng, Qiu Wei

СтатьяПеревод в очереди

Аннотация

In this study, we included 461 NMOSD patients at our hospital from January 2016 to June 2019 and got some results. Eight (1.9%) originally AQP4-IgG-seronegative patients were retested as seropositive. 221 patients (47.9%) did not receive immunosuppressive treatment within 3 month. The adult/child distribution was significantly different (p = 0.001). Thirty-three patients (7.2%) had relapses after drug withdrawal, and fifteen of them had used drugs ≥3 years. The conclusion is that decision to treat with immunosuppression was made less often in children than in adults. Patients who took medication for a long time still need to be cautious of stopping using immunosuppression.

Для цитирования: Li Cong, Wang Jingqi, Sun Xiaobo, Li Rui, Chang Yanyu, Wang Yuge, Zhong Xiaonan, Kermode Allan G, Mao Zhifeng, Qiu Wei. The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China.. Journal of neuroimmunology. 2021. DOI: 10.1016/j.jneuroim.2021.577506.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.